HCPLive Network

Gastric Bypass Drastically Lowers Cholesterol

TUESDAY, June 11 (HealthDay News) -- Compared to gastric banding, bariatric bypass surgery achieves greater cholesterol lowering, according to a study published in the June issue of Diabetes Care.

Alberto Benetti, MD, from Universita degli Studi di Milano, and colleagues assessed glucose metabolism (blood glucose and serum insulin levels and homeostasis model assessment of insulin resistance [HOMA-IR] index) and cholesterol metabolism (absorption: serum campesterol and sitosterol levels; synthesis: serum lathosterol levels; catabolism: rate of appearance and serum concentrations of serum 7-α- and serum 27-OH-cholesterol after infusions of deuterated 7-α- and 27-OH-cholesterol in sequence) in grade 3 obesity subjects undergoing bariatric bypass surgery and gastric banding. Measurements were taken before and six months after surgery.

The researchers found that baseline values were similar in all subjects. In both groups, weight loss and blood glucose, insulin levels, HOMA-IR, and triglycerides decreased similarly. Serum cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, serumsitosterol, and campesterol levels decreased and lathosterol levels increased only in bypass subjects. Serum 27-OH-cholesterol decreased in both groups, but only in the bypass group was there a significant increase in 7-α-OH-cholesterol.

"Malabsorptive surgery specifically affects cholesterol levels, independent of weight loss and independent of glucose metabolism and insulin resistance," the authors write.

Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Patients take longer to metabolize alcohol and return to a sober state after gastric bypass, and could have a few too many if they aren't aware.
The guidelines will help clinicians better manage co-morbidities such as weight regain, type 2 diabetes, polycystic ovarian syndrome, and sleep apnea.
Age is less important than BMI, cardiovascular health, diabetes, and other considerations when evaluating elderly patients for bariatric surgery.
A new clinical trial is enrolling patients with type 2 diabetes to determine for which patients a surgical option is most effective in treating the disease.
Study shows bariatric surgery can not only help obese patients lose weight, but also reduce their risk of developing atrial fibrillation.
Trial data presented at ACC.14 showed bariatric surgery was associated with much better long-term glycemic control in obese patients with diabetes compared with standard intensive medical therapy alone.
Long-term follow-up shows that, in patients with type 2 diabetes, bariatric surgery is associated with greater diabetes remission and fewer diabetes-related complications than usual care, according to a study published in the June 11 issue of the Journal of the American Medical Association, a theme issue on diabetes.
More Reading